186 related articles for article (PubMed ID: 37051547)
1. Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer.
Li C; Fan Z; Guo W; Liang F; Mao X; Wu J; Wang H; Xu J; Wu D; Liu H; Wang L; Li F
Front Oncol; 2023; 13():1149942. PubMed ID: 37051547
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Fibrinogen to Prealbumin Ratio (FPR) in Resectable Gastric Cancer.
Li H; Sun Y; Wang C; Xue Y
J Inflamm Res; 2024; 17():1325-1335. PubMed ID: 38434582
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer.
Tang S; Lin L; Cheng J; Zhao J; Xuan Q; Shao J; Zhou Y; Zhang Y
BMC Cancer; 2020 May; 20(1):382. PubMed ID: 32375697
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma.
Li H; Zhou F; Cao Z; Tang Y; Huang Y; Li Y; Yi B; Yang J; Du P; Zhu D; Zhou J
Front Oncol; 2021; 11():682969. PubMed ID: 34136406
[TBL] [Abstract][Full Text] [Related]
5. Value of the fibrinogen-platelet ratio in patients with resectable pancreatic cancer.
Arakawa Y; Miyazaki K; Yoshikawa M; Yamada S; Saito Y; Ikemoto T; Imura S; Morine Y; Shimada M
J Med Invest; 2021; 68(3.4):342-346. PubMed ID: 34759156
[TBL] [Abstract][Full Text] [Related]
6. A NOVEL PROGNOSTIC INDEX IN PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: FIBRINOGEN/PREALBUMIN RATIO.
Feng JF; Wang L; Jiang YH; Yang X
Rev Invest Clin; 2020; 72(1):46-54. PubMed ID: 32132740
[TBL] [Abstract][Full Text] [Related]
7. Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma.
Li S; Zhang X; Lou C; Gu Y; Zhao J
Front Oncol; 2022; 12():1003845. PubMed ID: 36387142
[TBL] [Abstract][Full Text] [Related]
8. Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients.
Wang F; Zhao Y; Xu J; Shao S; Yu D
Front Oncol; 2022; 12():1037672. PubMed ID: 36518321
[TBL] [Abstract][Full Text] [Related]
9. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a prognostic nomogram for colorectal cancer after surgery.
Li BW; Ma XY; Lai S; Sun X; Sun MJ; Chang B
World J Clin Cases; 2021 Jul; 9(21):5860-5872. PubMed ID: 34368305
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Preoperative Fibrinogen-to-Prealbumin Ratio in Patients with Stage I-III Colorectal Cancer Undergoing Surgical Resection: A Retrospective Cohort Study.
Hailun Xie ; Huang S; Yuan G; Tang S; Gan J
Biomed Res Int; 2021; 2021():3905353. PubMed ID: 33521127
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma.
Ren H; Wu CR; Aimaiti S; Wang CF
Oncol Lett; 2020 Jun; 19(6):4093-4105. PubMed ID: 32382348
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma.
Wang D; Pan B; Huang JC; Chen Q; Cui SP; Lang R; Lyu SC
Front Oncol; 2023; 13():1106029. PubMed ID: 37007095
[TBL] [Abstract][Full Text] [Related]
14. Development and Internal Validation of a Nomogram-Based Model to Predict Three-Year and Five-Year Overall Survival in Patients with Stage II/III Colon Cancer.
Ren D; Wang WL; Wang G; Chen WW; Li XK; Li GD; Bai SX; Dong HM; Chen WH
Cancer Manag Res; 2022; 14():225-236. PubMed ID: 35058717
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer.
Gu Y; Hua Q; Li Z; Zhang X; Lou C; Zhang Y; Wang W; Cai P; Zhao J
BMC Cancer; 2023 Mar; 23(1):227. PubMed ID: 36899319
[TBL] [Abstract][Full Text] [Related]
16. A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer.
Hua X; Duan F; Zhai W; Song C; Jiang C; Wang L; Huang J; Lin H; Yuan Z
J Inflamm Res; 2022; 15():381-394. PubMed ID: 35079223
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Assessment of Colorectal Cancer Patients after Laparoscopic Surgery: A Comprehensive Evaluation of the Glasgow Prognostic Score and Fibrinogen-to-Prealbumin Ratio.
Liu B; Qian J; Zhou Y; Chen N; Zhuang H; Wang J; Zhang X; Zhao H
Med Sci Monit; 2024 Feb; 30():e942658. PubMed ID: 38379279
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
19. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
Front Public Health; 2022; 10():969030. PubMed ID: 36203704
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
